In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment

In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment

Three carbapenem-resistant Klebsiella pneumoniae (CRKP; strains KP-426, KP-C76, and KP-CT77) were isolated from a patient with severe burns during the treatment of colistin and tigecycline. Single-nucleotide polymorphism typing showed that three ST11 CRKP were clonally related. Three isolates harbor...

Full description

Bibliographic Details
Main Authors:	Jiawei Chen, Yu Zeng, Rong Zhang, Jiachang Cai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Microbiology
Subjects:	carbapenem-resistant hypervirulent Klebsiella pneumonia colistin resistance mgrB tigecycline resistance tet(A)
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2021.702956/full

Similar Items

Role of the ISKpn element in mediating mgrB gene mutations in ST11 hypervirulent colistin-resistant Klebsiella pneumoniae
by: Lanlan Zhu, et al.
Published: (2023-09-01)

Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin
by: Xi Jin, et al.
Published: (2021-01-01)

MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258
by: Béla Kocsis, et al.
Published: (2017-10-01)

Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China
by: Xiaoyu Liu, et al.
Published: (2022-01-01)

Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Tao Wang, et al.
Published: (2023-12-01)

In vivo Emergence of Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Mediated by Premature Termination of the mgrB Gene Regulator
by: Yingying Kong, et al.
Published: (2021-06-01)

Genomic characterization of colistin-resistant Klebsiella pneumoniae isolated from intensive care unit patients in Egypt
by: Eriny T. Attalla, et al.
Published: (2023-09-01)

MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran
by: Mehri Haeili, et al.
Published: (2017-12-01)

Heteroresistance to colistin in wild-type Klebsiella pneumoniae isolates from clinical origin
by: Irene Sánchez-León, et al.
Published: (2023-12-01)

Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae strains
by: Miaomiao Xie, et al.
Published: (2024-12-01)

Insertion element mediated mgrB disruption and presence of ISKpn28 in colistin-resistant Klebsiella pneumoniae isolates from Saudi Arabia
by: Uz Zaman T, et al.
Published: (2018-08-01)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
by: Dakang Hu, et al.
Published: (2022-06-01)

Genetic Characterisation of Colistin Resistant Klebsiella pneumoniae Clinical Isolates From North India
by: Sanjay Singh, et al.
Published: (2021-06-01)

Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China
by: Xin Chen, et al.
Published: (2022-09-01)

Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19
by: Samaneh Pourajam, et al.
Published: (2023-03-01)

Evaluation of mechanisms of colistin resistance in Klebsiella pneumoniae strains isolated from patients with urinary tract infection in ICU
by: Mojtaba Niazadeh, et al.
Published: (2022-02-01)

Emergence of Tigecycline Nonsusceptible and IMP-4 Carbapenemase-Producing K2-ST65 Hypervirulent Klebsiella pneumoniae in China
by: Yawei Zhang, et al.
Published: (2021-10-01)

The Occurence of Colistin-Resistant Hypervirulent Klebsiellapneumoniae in China
by: Yang Lu, et al.
Published: (2018-10-01)

Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. Coli strains
by: Ching-Hsun Wang, et al.
Published: (2024-04-01)

Assessment of Colistin Heteroresistance among Multidrug-Resistant <i>Klebsiella pneumoniae</i> Isolated from Intensive Care Patients in Europe
by: Anouk J. M. M. Braspenning, et al.
Published: (2024-03-01)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021-09-01)

Evolution of tet(A) variant mediating tigecycline resistance in KPC-2-producing Klebsiella pneumoniae during tigecycline treatment
by: Wenli Liao, et al.
Published: (2022-03-01)

Infection with Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae: clinical, virulence and molecular epidemiological characteristics
by: Linlin Li, et al.
Published: (2023-11-01)

Hypervirulent carbapenem-resistant Klebsiella pneumoniae causing highly fatal meningitis in southeastern China
by: Na Huang, et al.
Published: (2022-10-01)

MgrB Mutations and Altered Cell Permeability in Colistin Resistance in <i>Klebsiella pneumoniae</i>
by: Polly Soo-Xi Yap, et al.
Published: (2022-09-01)

Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Yu-Ling Han, et al.
Published: (2022-09-01)

In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates
by: Mingju Hao, et al.
Published: (2020-03-01)

The Rapid Emergence of Tigecycline Resistance in blaKPC–2 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment
by: Xiaoxing Du, et al.
Published: (2018-04-01)

Change of Hypermucoviscosity in the Development of Tigecycline Resistance in Hypervirulent <i>Klebsiella pneumoniae</i> Sequence Type 23 Strains
by: Suyeon Park, et al.
Published: (2020-10-01)

Clinical and Molecular Characteristics of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Isolates in a Tertiary Hospital in Shanghai, China
by: Zhou C, et al.
Published: (2021-07-01)

Colistin Resistance Mechanisms in Human and Veterinary <i>Klebsiella pneumoniae</i> Isolates
by: Manuela Tietgen, et al.
Published: (2022-11-01)

Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China
by: Jun Li, et al.
Published: (2019-09-01)

Characterization of ST11 and ST15 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae from Patients with Ventilator-Associated Pneumonia
by: Song S, et al.
Published: (2023-09-01)

Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae
by: Subhankar Mukherjee, et al.
Published: (2021-06-01)

An Outbreak of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae in an Intensive Care Unit of a Major Teaching Hospital in Wenzhou, China
by: Yajie Zhao, et al.
Published: (2019-08-01)

Genomic epidemiology of hypervirulent carbapenem-resistant Klebsiella pneumoniae at Jinshan local hospital, Shanghai, during 2014–2018
by: Ming-Quan Guo, et al.
Published: (2024-02-01)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
by: Po-Han Huang, et al.
Published: (2022-06-01)

An Outbreak of ST859-K19 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Teaching Hospital
by: Junying Zhu, et al.
Published: (2022-06-01)

An outbreak of extensively drug-resistant and hypervirulent Klebsiella pneumoniae in an intensive care unit of a teaching hospital in Southwest China
by: Siyi Liu, et al.
Published: (2022-09-01)

Genomic Analysis of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Tertiary Hospital
by: Chen L, et al.
Published: (2023-09-01)